Heart Care For you

Cardiac Follow Up is the planned reassessment of a person after a cardiovascular diagnosis, event, or intervention. It is a clinical process (not a single test or disease) used to monitor symptoms, risk, and response to therapy. It is commonly encountered in outpatient cardiology clinics, hospital discharge pathways, and cardiac rehabilitation programs. It often combines history, examination, and targeted testing to guide ongoing care.

A Cardiac Telemetry Unit is a hospital care area where a patient’s heart rhythm is monitored continuously. It is a clinical setting (a type of inpatient unit), not a disease or a single test. It is commonly used in cardiology and hospital medicine to watch for arrhythmias and rhythm changes during acute illness. It is often encountered after emergency department evaluation, following cardiac procedures, or during treatment for cardiac symptoms.

Cardiac Plaque Burden describes how much atherosclerotic plaque is present in the coronary arteries. It is a clinical concept and imaging-based assessment, not a single disease or one specific test. It is commonly discussed in preventive cardiology, chest pain evaluation, and coronary artery disease risk stratification. It is most often estimated using cardiac imaging such as coronary computed tomography (CT) and coronary angiography-based techniques.

Coronary Flow Reserve is a physiologic measure of how much coronary blood flow can increase above its resting level. It is a cardiovascular physiology concept and a diagnostic metric, not a disease by itself. It is commonly encountered in chest pain evaluation, ischemia testing, and coronary microvascular assessment. It helps clinicians connect coronary anatomy with the heart’s ability to meet increased oxygen demand.

Three Dimensional Echo is an ultrasound-based cardiac imaging test that shows the heart in 3D. It is a diagnostic imaging technique within echocardiography. It is commonly encountered in valve disease, structural heart evaluation, and procedural guidance. It helps clinicians visualize cardiac anatomy in a way that resembles surgical or catheter-based views.

Global Longitudinal Strain is a quantitative imaging measurement of how the left ventricle shortens from base to apex during systole. It is a cardiac imaging metric (a test result), most commonly derived from transthoracic echocardiography using speckle-tracking. It is often encountered when evaluating heart failure, cardiomyopathies, valvular disease, and treatment-related cardiac dysfunction. It is used alongside left ventricular ejection fraction to describe systolic function in a more detailed way.

A Myocardial Perfusion Scan is a cardiac imaging test that evaluates blood flow to the heart muscle. It is a diagnostic test in nuclear cardiology that uses a small amount of radioactive tracer and a special camera. It is commonly encountered when evaluating chest pain, suspected coronary artery disease, or ischemia. It is often paired with “stress” (exercise or medication) and “rest” imaging to compare perfusion patterns.

Cardiac Stress Imaging is a diagnostic test category that evaluates how the heart performs when workload is increased. It combines “stress” (exercise or medication-induced physiologic demand) with imaging to look for reduced blood flow or impaired heart muscle function. It is commonly encountered when clinicians evaluate chest pain, shortness of breath with exertion, or suspected coronary artery disease. It is also used in cardiology to support risk stratification and to guide next diagnostic or treatment steps.

Cardiac Remodeling Therapy is a broad term for treatments intended to prevent, slow, or reverse harmful changes in heart size, shape, and function. It is a therapeutic concept and clinical goal rather than a single drug or procedure. It is most commonly discussed in heart failure, after myocardial infarction (heart attack), and in long-standing hypertension or valvular disease. Clinicians use it to frame treatment planning around improving ventricular function and long-term outcomes.

End Stage Heart Failure is an advanced form of heart failure where symptoms and functional limitations persist despite usual therapies. It is a clinical condition (not a single test or procedure) defined by severity, trajectory, and limited physiologic reserve. It is commonly encountered in inpatient cardiology, advanced heart failure clinics, and transplant or mechanical circulatory support programs. It often prompts discussions about advanced therapies and goals of care in a structured, team-based setting.